JENNIFER GRADEL: Open Payments
NPI 1700202959 · WARRENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 54 payments from 21 companies in 2025. Trend: 2023 $773 · 2024 $872 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $267 |
| Corcept Therapeutics | 5 | $109 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Lilly USA, LLC | 4 | $71 |
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| Novo Nordisk Inc | 3 | $56 |
| Amgen Inc. | 3 | $53 |
| Exact Sciences Corporation | 3 | $50 |
| ABBVIE INC. | 2 | $37 |
Products named: FARXIGA, Korlym, JARDIANCE, CAPLYTA, MOUNJARO, SPRAVATO, REXULTI, Ozempic.
Industry payments across MO — which companies pay providers there.
